- Active cellular immunotherapy of ovarian cancer using dendritic cells2012 | Second Faculty of Medicine
- Antiangiogenic therapy for ovarian cancer2013 | First Faculty of Medicine
- Treatment of recurrent ovarian cancer2009 | Publication without faculty affiliation
- Endometriosis and ovarian cancer2014 | Faculty of Medicine in Pilsen
- What to do with women with familial incidence of ovarian cancer?2008 | Faculty of Medicine in Hradec Králové
- Chemoresistance/Chemosensitivity of Ovarian Cancer +12008 | Faculty of Medicine in Hradec Králové
- Chemoresistance/Chemosensitivity of Ovarian Cancer2008 | First Faculty of Medicine
- The use of niraparib in the treatment of ovarian cancer2023 | First Faculty of Medicine
- Ovarian cancer stem cells2012 | Faculty of Medicine in Pilsen
- Hormone replacement therapy and ovarian cancer2012 | First Faculty of Medicine
- Proteomics and biomarkers for detection of ovarian cancer2009 | Faculty of Medicine in Hradec Králové
- Proteomics and biomarkers for detection of ovarian cancer2009 | First Faculty of Medicine
- Surgical resection of ovarian cancer: past, present and future2010 | Publication without faculty affiliation
- Medical treatment of primary ovarian cancer2016 | Publication without faculty affiliation
- Tailor made tumor immunotherapy vaccinePublication without faculty affiliation
- DNA hypermethylation in ovarian cancer2010 | Faculty of Medicine in Hradec Králové
- Cancer stem cells in ovarian cancer2012 | Faculty of Medicine in Pilsen
- Endometriosis and risk of ovarian cancer: what do we know?2020 | Faculty of Medicine in Pilsen
- Hereditary ovarian cancer2006 | Faculty of Physical Education and Sport
- Lysophosphatidic acid: an ovarian cancer marker2008 | First Faculty of Medicine
- HE4 a biomarker of ovarian cancer2012 | Faculty of Medicine in Pilsen
- Intestinal permeability - a prognostic indicator in ovarian cancer2008 | First Faculty of Medicine
- New trends in systemic treatment of ovarian cancer2018 | Faculty of Medicine in Pilsen
- Lysophosphatidic acid determination in ovarian cancer patients2006 | First Faculty of Medicine
- Ovarian cancer - hereditary disposition2018 | Faculty of Medicine in Pilsen
- Methylation in the p53 promoter in epithelial ovarian cancer2013 | Faculty of Medicine in Hradec Králové
- Inactivation of BRCA1, BRCA2 and p53 genes in sporadic ovarian cancer2008 | First Faculty of Medicine
- PARP inhibitors in the therapy of ovarian cancer2019 | Faculty of Medicine in Pilsen
- The principles of the surgical treatment in ovarian cancer patients2018 | Faculty of Medicine in Pilsen